Interaction of BDNF with Cytokines in Chronic Schizophrenia.

Xiang Yang Zhang,Yun-Long Tan,Da-Chun Chen,Shu-Ping Tan,Fu-De Yang,Hanjing Emily Wu,Giovana B. Zunta-Soares,Xu-Feng Huang,Thomas R. Kosten,Jair C. Soares

DOI: https://doi.org/10.1016/j.bbi.2015.09.014

IF: 19.227

2015-01-01

Brain Behavior and Immunity

Abstract:Brain-derived neurotrophic factor (BDNF) interacts with cytokines. Although both BDNF and cytokines occur at abnormal levels in schizophrenia patients, their interactions have not yet been examined. We therefore compared serum BDNF, TNF-α, interleukin (IL)-2, IL-6, and IL-8 levels in 92 chronically medicated schizophrenia patients and 60 healthy controls. We correlated these serum levels within these subject groups with each other and with clinical symptoms assessed according to the Positive and Negative Syndrome Scale (PANSS). Compared to the control group, the schizophrenia patients had significantly lower BDNF and TNF-α levels, and higher IL-2, IL-6, and IL-8 levels. The patients also showed a significant positive correlation between BDNF and both IL-2 and IL-8 levels, and low BDNF and TNF-α levels together were associated with poor performance on the PANSS cognitive factor. Thus, an interaction between cytokines and neurotrophic factors may be implicated in the pathophysiology of chronic schizophrenia. In particular, the cytokine TNF-α may interact with BNDF causing cognitive impairment.